|HCV NS3-4A serine protease|
|In vitro (25°C)||DMSO||136 mg/mL (200.04 mM)|
|Water||<1 mg/mL (<1 mM)|
|Ethanol||<1 mg/mL (<1 mM)|
|In vivo||30% PEG400/0.5% Tween80/5% propylene glycol||30 mg/mL|
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
|Concentration / Solvent Volume / Mass||1 mg||5 mg||10 mg|
|0.1 mM||14.71 mL||73.54 mL||147.08 mL|
|0.5 mM||2.94 mL||14.71 mL||29.42 mL|
|1 mM||1.47 mL||7.35 mL||14.71 mL|
|5 mM||0.29 mL||1.47 mL||2.94 mL|
*The above data is based on the productmolecular weight 679.9 . Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
|MECHANISM OF ACTION||Inhibitor|
|Storage||at -20°C 3 years Powder|
|Synonyms||VX950, Incivek, Incivo|
Ciluprevir is a specific and potent peptidomimetic inhibitor of the HCV NS3 protease.
Boceprevir is a protease inhibitor used as a treatment for hepatitis C genotype 1.
VX-222 is a small molecule non-nucleoside inhibitor of HCV NS5B polymerase that is being investigated for the treatment of hepatitis C virus…
BMS-790052 is an NS5A inhibitor under investigation for the treatment of hepatitis C virus (HCV) infection.
Balapiravir (R1626, RG1626) is the prodrug of a nucleoside analogue inhibitor of the hepatitis C virus (HCV) RNA-dependent RNA polymerase (R…